Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Epithelial Cervical Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00045526
What this trial is testing

Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionRecurrent Esophageal Cancer+3 more
National Cancer Institute (NCI) 48
Large-scale testing (Phase 3)Study completedNCT00002533
What this trial is testing

Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerInfectionOral Complications
University of Miami
Testing effectiveness (Phase 2)Study completedNCT00005599
What this trial is testing

Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00020189
What this trial is testing

Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck CancerThromboembolism
National Cancer Institute (NCI)
Large-scale testing (Phase 3)WithdrawnNCT04129320
What this trial is testing

Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of Head and Neck
MacroGenics
Testing effectiveness (Phase 2)Ended earlyNCT00573989
What this trial is testing

Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Wake Forest University Health Sciences 27
Testing effectiveness (Phase 2)Study completedNCT00098813
What this trial is testing

Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine

Who this might be right for
Recurrent Thyroid CancerStage IV Follicular Thyroid CancerStage IV Papillary Thyroid Cancer
National Cancer Institute (NCI) 20
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)WithdrawnNCT01674374
What this trial is testing

Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy

Who this might be right for
MucositisRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+29 more
Roswell Park Cancer Institute
Not applicableLooking for participantsNCT06561178
What this trial is testing

Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-Sen University Cancer Center 50
Testing effectiveness (Phase 2)UnknownNCT00003257
What this trial is testing

Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Aventis Pharmaceuticals 39
Early research (Phase 1)Ended earlyNCT00004261
What this trial is testing

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Who this might be right for
Breast CancerCervical CancerHead and Neck Cancer+2 more
University Health Network, Toronto
Large-scale testing (Phase 3)Looking for participantsNCT06228079
What this trial is testing

Adjuvant vs Surgery Only in Early-stage Recurrent NPC

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University 176
Testing effectiveness (Phase 2)UnknownNCT05162872
What this trial is testing

Niraparib And Sintilimab In Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 99
Testing effectiveness (Phase 2)UnknownNCT03854838
What this trial is testing

IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal NeoplasmsNasopharyngeal Diseases+1 more
Sun Yat-sen University 25
Early research (Phase 1)Study completedNCT00011778
What this trial is testing

PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma
National Cancer Institute (NCI) 25
Early research (Phase 1)Study completedNCT00021424
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck CancerMetastatic Cancer
National Institute on Deafness and Other Communication Disorders (NIDCD)
Not applicableStudy completedNCT00897273
What this trial is testing

Oral HPV Infection in Young Men

Who this might be right for
Head and Neck CancerInfectionPrecancerous Condition
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 500
Large-scale testing (Phase 3)Study completedNCT02252042
What this trial is testing

Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)

Who this might be right for
Head and Neck Squamous Cell Cancer
Merck Sharp & Dohme LLC 495
Testing effectiveness (Phase 2)Ended earlyNCT04220775
What this trial is testing

Bintrafusp Alfa and Stereotactic Body Radiation Therapy for the Treatment of Recurrent or Second Primary Head and Neck Squamous Cell Cancer

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaSecond Primary Squamous Cell Carcinoma of the Head and Neck
M.D. Anderson Cancer Center 3
Next Page